Trials / Completed
CompletedNCT00418639
Study of Nitazoxanide in the Treatment of Chronic Hepatitis C
Randomized, Double-Blind, Placebo-Controlled Study of Nitazoxanide in the Treatment of Chronic Hepatitis C
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 50 (planned)
- Sponsor
- Romark Laboratories L.C. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study will evaluate the effect of treatment with 24 weeks nitazoxanide monotherapy on end of treatment virologic response, sustained virologic response, reduction of quantitative serum HCV RNA, changes in ALT and safety parameters.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Nitazoxanide |
Timeline
- Start date
- 2005-02-01
- First posted
- 2007-01-05
- Last updated
- 2007-01-05
Locations
3 sites across 1 country: Egypt
Source: ClinicalTrials.gov record NCT00418639. Inclusion in this directory is not an endorsement.